ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980

Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL

May 25, 2012

NCI Staff Finishes Center Program Study, Submits Recommendations

February 25, 1977

Also in this 8-page issue: Intel Chairman Andrew Grove slams NCI director and cancer program for “wishful dreams” and “chemo speeches,” recommends moratorium on funding for cancer research.

May 14, 2004

In Brief: Administration Ignores Congressional Mandate To Revive Training Grants, Funds Fellowships

February 8, 1974

Hatch Committee Clears Bill Blocking OMB Micromanagement

August 15, 1986